Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 3
2019 4
2020 12
2021 8
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Factors Associated With Condom Failure in a Longitudinal Cohort of Men Who Have Sex With Men and Transgender Women in Abuja and Lagos, Nigeria.
Hamill MM, Hu F, Kokogho A, Shoyemi E, Ekeh C, Charurat ME, Robb ML, Adebajo S, Baral SD, Nowak RG, Crowell TA; TRUST/RV368 Study Group. Hamill MM, et al. Among authors: kokogho a. J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):329-338. doi: 10.1097/QAI.0000000000002559. J Acquir Immune Defic Syndr. 2021. PMID: 33234806 Free PMC article.
Hepatitis B virus infection among men who have sex with men and transgender women living with or at risk for HIV: a cross sectional study in Abuja and Lagos, Nigeria.
Adeyemi OA, Mitchell A, Shutt A, Crowell TA, Ndembi N, Kokogho A, Ramadhani HO, Robb ML, Baral SD, Ake JA, Charurat ME, Peel S, Nowak RG; TRUST/RV368 study group. Adeyemi OA, et al. Among authors: kokogho a. BMC Infect Dis. 2021 Jul 6;21(1):654. doi: 10.1186/s12879-021-06368-1. BMC Infect Dis. 2021. PMID: 34229613 Free PMC article.
Individual and partnership characteristics associated with consistent condom use in a cohort of cisgender men who have sex with men and transgender women in Nigeria.
Olawore O, Crowell TA, Ketende SC, Ramadhani HO, Liu H, Ake JA, Kokogho A, Adebajo S, Charurat ME, Nowak RG, Baral SD; TRUST/RV368 Study Group. Olawore O, et al. Among authors: kokogho a. BMC Public Health. 2021 Jun 30;21(1):1277. doi: 10.1186/s12889-021-11275-w. BMC Public Health. 2021. PMID: 34193101 Free PMC article.
Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials.
Korang SK, von Rohden E, Veroniki AA, Ong G, Ngalamika O, Siddiqui F, Juul S, Nielsen EE, Feinberg JB, Petersen JJ, Legart C, Kokogho A, Maagaard M, Klingenberg S, Thabane L, Bardach A, Ciapponi A, Thomsen AR, Jakobsen JC, Gluud C. Korang SK, et al. Among authors: kokogho a. PLoS One. 2022 Jan 21;17(1):e0260733. doi: 10.1371/journal.pone.0260733. eCollection 2022. PLoS One. 2022. PMID: 35061702 Free PMC article.
Retention of a cohort of men who have sex with men and transgender women at risk for and living with HIV in Abuja and Lagos, Nigeria: a longitudinal analysis.
Kayode BO, Mitchell A, Ndembi N, Kokogho A, Ramadhani HO, Adebajo S, Robb ML, Baral SD, Ake JA, Charurat ME, Crowell TA, Nowak RG; TRUST/RV368 Study Group. Kayode BO, et al. Among authors: kokogho a. J Int AIDS Soc. 2020 Oct;23 Suppl 6(Suppl 6):e25592. doi: 10.1002/jia2.25592. J Int AIDS Soc. 2020. PMID: 33000914 Free PMC article.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Tapia MD, Sow SO, Ndiaye BP, Mbaye KD, Thiongane A, Ndour CT, Mboup S, Ake JA, Keshinro B, Akintunde GA, Kinge TN, Vernet G, Bigna JJ, Oguche S, Koram KA, Asante KP, Hogrefe WR, Günther S, Naficy A, De Ryck I, Debois M, Bourguignon P, Jongert E, Ballou WR, Koutsoukos M, Roman F; Zaire EBola Research Alliance group. Tapia MD, et al. Lancet Infect Dis. 2020 Jun;20(6):707-718. doi: 10.1016/S1473-3099(20)30016-5. Epub 2020 Mar 19. Lancet Infect Dis. 2020. PMID: 32199491 Clinical Trial.
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.
Tapia MD, Sow SO, Mbaye KD, Thiongane A, Ndiaye BP, Ndour CT, Mboup S, Keshinro B, Kinge TN, Vernet G, Bigna JJ, Oguche S, Koram KA, Asante KP, Gobert P, Hogrefe WR, De Ryck I, Debois M, Bourguignon P, Jongert E, Ballou WR, Koutsoukos M, Roman F; Zaire EBola Research Alliance group. Tapia MD, et al. Lancet Infect Dis. 2020 Jun;20(6):719-730. doi: 10.1016/S1473-3099(20)30019-0. Epub 2020 Mar 19. Lancet Infect Dis. 2020. PMID: 32199492 Clinical Trial.
34 results